Comment
. 2007 Mar 1;356(9):961; author reply 962-3.
Tolvaptan for hyponatremia
- PMID: 17338052
Item in Clipboard
Comment
Tolvaptan for hyponatremia
N Engl J Med.
.
No abstract available
Comment on
-
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.N Engl J Med. 2006 Nov 16;355(20):2099-112. doi: 10.1056/NEJMoa065181. Epub 2006 Nov 14. N Engl J Med. 2006. PMID: 17105757 Clinical Trial.
Similar articles
-
Tolvaptan for hyponatremia.N Engl J Med. 2007 Mar 1;356(9):962; author reply 962-3. N Engl J Med. 2007. PMID: 17338053 No abstract available.
-
Tolvaptan.Br J Clin Pharmacol. 2012 Jan;73(1):9-11. doi: 10.1111/j.1365-2125.2011.04029.x. Br J Clin Pharmacol. 2012. PMID: 21623874 Free PMC article. No abstract available.
-
Tolvaptan for hyponatremia.N Engl J Med. 2007 Mar 1;356(9):961; author reply 962-3. doi: 10.1056/NEJMc063545. N Engl J Med. 2007. PMID: 17329708 No abstract available.
-
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.Clin Ther. 2010 Jun;32(6):1015-32. doi: 10.1016/j.clinthera.2010.06.015. Clin Ther. 2010. PMID: 20637957 Review.
-
Management of hyponatremia.CMAJ. 2014 May 13;186(8):E281-6. doi: 10.1503/cmaj.120887. Epub 2013 Dec 16. CMAJ. 2014. PMID: 24344146 Free PMC article. Review. No abstract available.
Cited by
-
Current and future treatment options in SIADH.NDT Plus. 2009 Nov;2(Suppl_3):iii12-iii19. doi: 10.1093/ndtplus/sfp154. NDT Plus. 2009. PMID: 19881932 Free PMC article.
-
SIADH and hyponatraemia: why does it matter?NDT Plus. 2009 Nov;2(Suppl_3):iii5-iii11. doi: 10.1093/ndtplus/sfp153. NDT Plus. 2009. PMID: 19881934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources